Restricted use of albumin for spontaneous bacterial peritonitis.
作者信息
Sigal Samuel H, Stanca Carmen M, Fernandez Javier, Arroyo Vicente, Navasa Miguel
出版信息
Gut. 2007 Apr;56(4):597-9. doi: 10.1136/gut.2006.113050.
Abstract
摘要
相似文献
1
Restricted use of albumin for spontaneous bacterial peritonitis.
Gut. 2007 Apr;56(4):597-9. doi: 10.1136/gut.2006.113050.
2
Intravenous albumin for spontaneous bacterial peritonitis in patients with cirrhosis.
N Engl J Med. 1999 Aug 5;341(6):443-4. doi: 10.1056/NEJM199908053410610.
3
Albumin infusion for spontaneous bacterial peritonitis.
Lancet. 1999 Nov 27;354(9193):1838-9. doi: 10.1016/S0140-6736(99)00303-7.
4
Intravenous albumin in patients with cirrhosis and spontaneous bacterial peritonitis.
N Engl J Med. 1999 Dec 2;341(23):1773-4. doi: 10.1056/NEJM199912023412317.
5
Drug insight: the role of albumin in the management of chronic liver disease.
Nat Clin Pract Gastroenterol Hepatol. 2007 Jan;4(1):43-51. doi: 10.1038/ncpgasthep0680.
6
Switch therapy with ciprofloxacin vs. intravenous ceftazidime in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis: similar efficacy at lower cost.
Aliment Pharmacol Ther. 2006 Jan 1;23(1):75-84. doi: 10.1111/j.1365-2036.2006.02706.x.
7
A randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis.
Hepatology. 2005 Sep;42(3):627-34. doi: 10.1002/hep.20829.
8
[Spontaneous bacterial peritonitis, a severe complication in patients with liver cirrhosis].
Ned Tijdschr Geneeskd. 2007 Jun 2;151(22):1258; author reply 1258-9.
9
[Ascites, spontaneous bacterial peritonitis and hepatorenal syndrome].
Dtsch Med Wochenschr. 2005 Dec 16;130 Suppl 5:S237-9.
10
Management of ascites in the patient with portal hypertension with emphasis on spontaneous bacterial peritonitis.
Semin Gastrointest Dis. 1997 Oct;8(4):200-9.
引用本文的文献
1
Asia-Pacific association for study of liver guidelines on management of ascites in liver disease.
Hepatol Int. 2023 Aug;17(4):792-826. doi: 10.1007/s12072-023-10536-7. Epub 2023 May 26.
2
Step by Step: Managing the Complications of Cirrhosis.
Hepat Med. 2021 May 25;13:45-57. doi: 10.2147/HMER.S278032. eCollection 2021.
3
Current Status and Prospects of Spontaneous Peritonitis in Patients with Cirrhosis.
Biomed Res Int. 2020 Jul 6;2020:3743962. doi: 10.1155/2020/3743962. eCollection 2020.
4
Clinical audit to determine efficacy of daily infusion of low dose of 20% albumin in combination with antibiotics in patients with spontaneous bacterial peritonitis.
Clin Exp Hepatol. 2019 Nov;5(4):301-307. doi: 10.5114/ceh.2019.88774. Epub 2019 Oct 16.
5
KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications.
Clin Mol Hepatol. 2018 Sep;24(3):230-277. doi: 10.3350/cmh.2018.1005. Epub 2018 Jul 9.
6
Role of albumin in cirrhosis: from a hospitalist's perspective.
J Community Hosp Intern Med Perspect. 2017 Mar 31;7(1):8-14. doi: 10.1080/20009666.2017.1302704. eCollection 2017 Jan.
7
Ascites, refractory ascites and hyponatremia in cirrhosis.
Gastroenterol Rep (Oxf). 2017 May;5(2):104-112. doi: 10.1093/gastro/gox010. Epub 2017 Apr 24.
8
Hepatobiliary Quiz Answers - 18 (2016).
J Clin Exp Hepatol. 2016 Jun;6(2):159-63. doi: 10.1016/j.jceh.2016.06.174. Epub 2016 Jul 25.
9
AISF-SIMTI position paper: the appropriate use of albumin in patients with liver cirrhosis.
Blood Transfus. 2016 Jan;14(1):8-22. doi: 10.2450/2016.0294-15.
10
Efficacy and safety of alternating norfloxacin and rifaximin as primary prophylaxis for spontaneous bacterial peritonitis in cirrhotic ascites: a prospective randomized open-label comparative multicenter study.
Hepatol Int. 2016 Mar;10(2):377-85. doi: 10.1007/s12072-015-9688-z. Epub 2015 Dec 10.
本文引用的文献
1
Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis.
J Hepatol. 2004 Sep;41(3):384-90. doi: 10.1016/j.jhep.2004.05.009.
2
Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis.
Hepatology. 2003 Nov;38(5):1210-8. doi: 10.1053/jhep.2003.50447.
3
Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club.
J Hepatol. 2000 Jan;32(1):142-53. doi: 10.1016/s0168-8278(00)80201-9.
4
Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.
N Engl J Med. 1999 Aug 5;341(6):403-9. doi: 10.1056/NEJM199908053410603.
5
Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality.
Hepatology. 1998 May;27(5):1227-32. doi: 10.1002/hep.510270507.
6
Long-lasting NO overproduction in cirrhotic patients with spontaneous bacterial peritonitis.
Hepatology. 1997 Jun;25(6):1328-33. doi: 10.1002/hep.510250604.
7
8
Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis.
Hepatology. 1994 Dec;20(6):1495-501. doi: 10.1002/hep.1840200619.
Zotero 插件